instagram story viewer > #nsclc

#nsclc

Posts
A lot of buzz about EGFR positive NSCLC since #WCLC25 after the FLAURA2 presentation. What do you need to know? Watch this (> 90 seconds😅) reel to learn more. Disclaimer: This post is for educational purposes only. It is not medical advice. Please always talk to your own healthcare team for guidance specific to your situation. — — #lungcancer #cancerresearch
A lot of buzz about EGFR positive NSCLC since #WCLC25 after the FLAURA2 presentation. What do you need to know? Watch this (> 90 seconds😅) reel to learn more. Disclaimer: This post is for educational purposes only. It is not medical advice. Please always talk to your own healthcare team for guidance specific to your situation. — — #lungcancer #cancerresearch
World First: Patient Receives Personalized mRNA Vaccine for Lung Cancer In a historic milestone, the UK has kicked off the first clinical trial of a bespoke mRNA vaccine designed to fight non-small cell lung cancer (NSCLC)—the most common and deadly form of the disease. Developed by BioNTech (pioneers of the COVID mRNA tech), the vaccine—called BNT116—uses personalized mRNA to teach the immune system to spot and destroy unique markers on a patient’s tumor cells. The first recipient? 67-year-old Janusz Racz, who just got his dose at University College London Hospitals (UCLH) after finishing standard treatment. The phase 1 trial is small—just 20 patients—but the goal is huge: turn the body’s own defenses into a precision weapon that prevents cancer from returning. Unlike brutal chemo that hits everything, this approach is tailored to each person’s tumor genetics, sparking a targeted immune assault with potentially far fewer side effects. If it succeeds, personalized mRNA vaccines could revolutionize cancer care—offering renewed hope against one of humanity’s biggest killers. #mRNAVaccine #LungCancer #CancerBreakthrough #PersonalizedMedicine #Immunotherapy #BioNTech #CancerResearch #MedicalInnovation #HopeForCancer #Oncology #alchetron #viral Read more: https://alchetron.com/Cancer-vaccine
World First: Patient Receives Personalized mRNA Vaccine for Lung Cancer In a historic milestone, the UK has kicked off the first clinical trial of a bespoke mRNA vaccine designed to fight non-small cell lung cancer (NSCLC)—the most common and deadly form of the disease. Developed by BioNTech (pioneers of the COVID mRNA tech), the vaccine—called BNT116—uses personalized mRNA to teach the immune system to spot and destroy unique markers on a patient’s tumor cells. The first recipient? 67-year-old Janusz Racz, who just got his dose at University College London Hospitals (UCLH) after finishing standard treatment. The phase 1 trial is small—just 20 patients—but the goal is huge: turn the body’s own defenses into a precision weapon that prevents cancer from returning. Unlike brutal chemo that hits everything, this approach is tailored to each person’s tumor genetics, sparking a targeted immune assault with potentially far fewer side effects. If it succeeds, personalized mRNA vaccines could revolutionize cancer care—offering renewed hope against one of humanity’s biggest killers. #mRNAVaccine #LungCancer #CancerBreakthrough #PersonalizedMedicine #Immunotherapy #BioNTech #CancerResearch #MedicalInnovation #HopeForCancer #Oncology #alchetron #viral Read more: https://alchetron.com/Cancer-vaccine
In April 2024, Samantha Murrell was diagnosed with stage 4 non-small cell lung adenocarcinoma (NSCLC) with a HER2 mutation. Her most recent scans show that her treatment is working. The medication she’s on is a targeted therapy designed specifically for HER2 mutations—a treatment that didn’t exist for lung cancer just a few years ago. Samantha recently shared a message of gratitude for the researchers and scientists behind this breakthrough. Their work is giving her more time with the people she loves and hope for the future. You can read more of Samantha's story through the link in our bio.
In April 2024, Samantha Murrell was diagnosed with stage 4 non-small cell lung adenocarcinoma (NSCLC) with a HER2 mutation. Her most recent scans show that her treatment is working. The medication she’s on is a targeted therapy designed specifically for HER2 mutations—a treatment that didn’t exist for lung cancer just a few years ago. Samantha recently shared a message of gratitude for the researchers and scientists behind this breakthrough. Their work is giving her more time with the people she loves and hope for the future. You can read more of Samantha's story through the link in our bio.
#lungcancercare #londononcology #targetedtherapy #nsclc#oncologyexpert Full article: https://oncologist.london/insights/how-long-can-you-live-with-stage-4-lung-cancer-and-what-can-you-do/
#lungcancercare #londononcology #targetedtherapy #nsclc#oncologyexpert Full article: https://oncologist.london/insights/how-long-can-you-live-with-stage-4-lung-cancer-and-what-can-you-do/
64-year-old man with non–small cell lung cancer (NSCLC) of the left lung presents with: 🧠 Headache ⚡ New-onset seizures for 3 weeks MRI findings shown in this reel. In a known cancer patient with new neurological symptoms, what should you suspect first? Is this: • Brain metastasis? • Primary brain tumor? • Radiation necrosis? • Infection? Think clinical context. Think imaging pattern. Drop your diagnosis in the comments 👇 #BrainMetastasis #LungCancer #NSCLC #Seizures #Oncology
64-year-old man with non–small cell lung cancer (NSCLC) of the left lung presents with: 🧠 Headache ⚡ New-onset seizures for 3 weeks MRI findings shown in this reel. In a known cancer patient with new neurological symptoms, what should you suspect first? Is this: • Brain metastasis? • Primary brain tumor? • Radiation necrosis? • Infection? Think clinical context. Think imaging pattern. Drop your diagnosis in the comments 👇 #BrainMetastasis #LungCancer #NSCLC #Seizures #Oncology
For Samantha, who is living with non-small cell lung cancer (NSCLC) and her husband Justin, it's the small yet significant moments that matter most, even in the toughest times. Discover how small things can create big impacts by visiting the link in our bio. #LifeForward #Oncology
For Samantha, who is living with non-small cell lung cancer (NSCLC) and her husband Justin, it's the small yet significant moments that matter most, even in the toughest times. Discover how small things can create big impacts by visiting the link in our bio. #LifeForward #Oncology
Survival should never be based on wealth. People should never have to crowd fund to pay for treatment or go without treatment because of a lack of money. Nobody asks for a cancer diagnosis Survival should be based on the person's health not wealth. #CancerSurvivor #cancerfighter #treatment #healthcare #moneytalks #egfr #nsclc
Survival should never be based on wealth. People should never have to crowd fund to pay for treatment or go without treatment because of a lack of money. Nobody asks for a cancer diagnosis Survival should be based on the person's health not wealth. #CancerSurvivor #cancerfighter #treatment #healthcare #moneytalks #egfr #nsclc
Roxanne had no idea that she had cancer. When she was diagnosed with non-small cell lung cancer (NSCLC), she had no symptoms. In this emotional video, Roxanne describes the moment she found out she had cancer to going in for emergency surgery. #lungcancer #cancersymptoms #cancerdiagnosis #cancer #thepatientstory Thank you AbbVie for its support of our patient story. The Patient Story retains full editorial control over all content.
Roxanne had no idea that she had cancer. When she was diagnosed with non-small cell lung cancer (NSCLC), she had no symptoms. In this emotional video, Roxanne describes the moment she found out she had cancer to going in for emergency surgery. #lungcancer #cancersymptoms #cancerdiagnosis #cancer #thepatientstory Thank you AbbVie for its support of our patient story. The Patient Story retains full editorial control over all content.
Comprehensive #biomarker testing is key in determining treatment options for non-small cell #lungcancer. However, many patients—especially those of color—are overlooked when it comes to this step and they face barriers to finding the right care plan. As we continue in Black History Month, we want to emphasize the need to close the care gap and ensure there is #NoOneMissed in the #NSCLC community. Explore our site to learn about #biomarkertesting and find tips to start the conversation with your doctor today: no1missed.org/47AOGjK
Comprehensive #biomarker testing is key in determining treatment options for non-small cell #lungcancer. However, many patients—especially those of color—are overlooked when it comes to this step and they face barriers to finding the right care plan. As we continue in Black History Month, we want to emphasize the need to close the care gap and ensure there is #NoOneMissed in the #NSCLC community. Explore our site to learn about #biomarkertesting and find tips to start the conversation with your doctor today: no1missed.org/47AOGjK
Biomarker testing played a pivotal role in shaping Samantha’s non-small cell lung cancer (NSCLC) journey. Working closely with her care team, she learned her cancer was driven by a HER2 genetic mutation—a discovery that unlocked targeted treatment options and a plan tailored specifically for her cancer. Samantha encourages everyone living with cancer to ask their care teams about biomarker testing. #ASCO #CancerCare #LifeForward
Biomarker testing played a pivotal role in shaping Samantha’s non-small cell lung cancer (NSCLC) journey. Working closely with her care team, she learned her cancer was driven by a HER2 genetic mutation—a discovery that unlocked targeted treatment options and a plan tailored specifically for her cancer. Samantha encourages everyone living with cancer to ask their care teams about biomarker testing. #ASCO #CancerCare #LifeForward
Lung cancer can spread beyond the lungs, silently journeying to other sites in the body. People living with non-small cell lung cancer (NSCLC), who have specific genetic mutations such as HER2, have an increased risk of their cancer spreading to the brain. This progression often goes unnoticed but affects 16-20% of people living with lung cancer. Early recognition of symptoms like cognitive changes, headaches, and seizures is vital for effective management and improving quality of life for people living with lung cancer. Learn more about brain metastasis in lung cancer via the link in our bio. #LifeForward #Oncology
Lung cancer can spread beyond the lungs, silently journeying to other sites in the body. People living with non-small cell lung cancer (NSCLC), who have specific genetic mutations such as HER2, have an increased risk of their cancer spreading to the brain. This progression often goes unnoticed but affects 16-20% of people living with lung cancer. Early recognition of symptoms like cognitive changes, headaches, and seizures is vital for effective management and improving quality of life for people living with lung cancer. Learn more about brain metastasis in lung cancer via the link in our bio. #LifeForward #Oncology
This #WorldLungCancerDay, we’re recognizing how science is helping us see lung cancer in new ways and pushing us toward better answers. At Johnson & Johnson, we’re driving innovation that’s shaping the future of #LungCancer care, grounded in science and focused on what matters to patients. #JNJOncology #NSCLC
This #WorldLungCancerDay, we’re recognizing how science is helping us see lung cancer in new ways and pushing us toward better answers. At Johnson & Johnson, we’re driving innovation that’s shaping the future of #LungCancer care, grounded in science and focused on what matters to patients. #JNJOncology #NSCLC
back to up